- China announced sanctions on U.S. entities linked to one of South Korea’s largest shipbuilders
- Investors fear that the trade escalation between US and China will persist longer
- Goldman Sachs and BlackRock shares are down in pre-market despite solid Q3 earnings reports
- China announced sanctions on U.S. entities linked to one of South Korea’s largest shipbuilders
- Investors fear that the trade escalation between US and China will persist longer
- Goldman Sachs and BlackRock shares are down in pre-market despite solid Q3 earnings reports
US stocks tumbled after China intensified its trade dispute with the United States, reigniting fears of a renewed confrontation between Beijing and Washington. The escalation comes at a time when equities already appear stretched in valuation following a months-long rally. China announced sanctions on U.S. entities linked to one of South Korea’s largest shipbuilders and signalled that further measures could follow. What's important, last time the US announced military partnership with South Korea in navy ship-building.
Investor focus is now turning toward the unofficial start of earnings season, with BlackRock shares down almost 1% in after-market trading despite a rock-solid earnings report from Q3; also, Goldman Sachs shares are down 2% after the report. Traders will be watching closely for insights on the sustainability of AI-related investments and the potential fallout from higher trade tariffs in the months ahead. US100 falls 1% today, falling to 24,600 points and try to maintain above EMA50. Falling below 24,300 points may potentially open the way for a larger sell-off.
Source: xStation5
US OPEN: Wall street extends declines! 📉
WTI Crude Plunges Over 2% to Lowest Level Since May
Coffee Futures Soar 5%, Break 400 Cents per Pound
Technical look: Gold falls from the record highđź””
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
